STAT Plus: Madrigal wins first U.S. approval for drug to treat liver disease MASH
Rezdiffra, a pill developed by Madrigal Pharmaceuticals, targets a protein directly in the liver that reduces liver fat, inflammation, and scarring.
Read The StoryFDA news roundup. Food and Drug Administration stories include proposed changes to nutrition fact labels, the safety of the pharmaceutical supply chain, regulating high blood pressure devices, and a fact check on Vivek Ramaswamy’s call to gut the FDA.
Other stories include FDA approval of Pfizer’s RSV vaccine, an approved treatment for a rare bone disease, and a warning over misleading promotional materials for a COPD drug.
Rezdiffra, a pill developed by Madrigal Pharmaceuticals, targets a protein directly in the liver that reduces liver fat, inflammation, and scarring.
Read The Storyadvertisement